PCRX Financing Cash Flow
Pacira Biosciences Inc · Financing Cash Flow
PCRX Financing Cash Flow
Latest reported-$376.18Mperiod ending
PCRX TTM Cash from Financing ($50.71M → -$376.18M)
TTM financing cash flow
High-resolution chart · PNG
PCRX financing cash flow history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | Financing Cash Flow (USD) |
|---|---|
| -376,176,000 | |
| -426,031,000 | |
| -369,627,000 | |
| -319,930,000 | |
| -65,299,000 | |
| 17,186,000 | |
| 17,363,000 | |
| 17,539,000 | |
| -7,403,000 | |
| -31,943,000 | |
| -183,031,000 | |
| -239,763,000 | |
| -219,751,000 | |
| -373,848,000 | |
| -401,528,000 | |
| 18,392,000 | |
| 29,219,000 | |
| 188,784,000 | |
| 380,694,000 | |
| 29,648,000 | |
| 236,354,000 | |
| 233,910,000 | |
| 222,304,000 | |
| 209,921,000 | |
| 1,586,000 | |
| 1,859,000 | |
| 3,670,000 | |
| 9,218,000 | |
| 10,777,000 | |
| 9,065,000 | |
| 8,954,000 | |
| 7,706,000 | |
| 7,412,000 | |
| 7,725,000 | |
| 224,162,000 | |
| 222,952,000 | |
| 221,033,000 | |
| 221,076,000 | |
| 7,261,000 | |
| 8,363,000 | |
| 9,417,000 | |
| 9,693,000 | |
| 10,699,000 | |
| 11,263,000 | |
| 11,821,000 | |
| 120,958,000 | |
| 118,875,000 | |
| 116,952,000 | |
| 115,550,000 | |
| 4,943,000 | |
| 89,165,000 | |
| 88,589,000 | |
| 87,860,000 | |
| 150,676,000 | |
| 63,610,000 | |
| 112,503,000 | |
| 112,264,000 | |
| 48,261,000 | |
| 87,158,000 | |
| 59,097,000 | |
| 69,396,000 | |
| 81,221,000 | |
| 50,705,000 | |
| 31,862,000 | |
| 29,754,000 |